Oncopharmpod
Polatuzumab-vedotin
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:29
- Mas informaciones
Informações:
Sinopsis
A newly approved drug for relapsed/refractory diffuse large B-cell lymphoma is discussed as well as PBR.
A newly approved drug for relapsed/refractory diffuse large B-cell lymphoma is discussed as well as PBR.
